Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adex Gel for actinic keratosis
ISRCTN11929806Phase 4Recruiting
- Sponsor
- Dermal Laboratories
- Start
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of adapalene in actinic keratosis (AK), sponsored by Dermal Laboratories. Primary endpoint: Actinic Keratosis Area and Severity Index at week 12. Started Jun 2026; status: recruiting.
02
Drugs
adapalene
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on ISRCTN11929806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11929806.